Inspiremd Stock Investor Sentiment

NSPR Stock  USD 2.77  0.06  2.21%   
Slightly above 55% of InspireMD's retail investors are presently thinking to get in. The analysis of overall sentiment of trading InspireMD stock suggests that some investors are interested at this time. InspireMD's investing sentiment overview a quick insight into current market opportunities from investing in InspireMD. Many technical investors use InspireMD stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  

InspireMD Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards InspireMD can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over six months ago at globenewswire.com         
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
Macroaxis News: globenewswire.com
over six months ago at seekingalpha.com         
InspireMD GAAP EPS of -0.21, revenue of 1.51M
seekingalpha News
over six months ago at investorplace.com         
NSPR Stock Earnings InspireMD Misses EPS, Beats Revenue for Q1 2024
sbwire news
over six months ago at investing.com         
Earnings call InspireMD reports growth in CGuard revenue for Q1
Investing News at Macroaxis
over six months ago at seekingalpha.com         
InspireMD Q1 2024 Earnings Preview
seekingalpha News
over six months ago at simplywall.st         
InspireMD Insiders Enjoying US133k Appreciation On US526.5k Investment
Simply Wall St News at Macroaxis
over six months ago at simplywall.st         
Disposition of tradable shares by Verta Patrick of InspireMD subject to Rule 16b-3
Simply Wall St News at Macroaxis
over six months ago at news.google.com         
InspireMD Coverage Initiated by Analysts at StockNews.com - MarketBeat
Google News at Macroaxis
over six months ago at finance.yahoo.com         
InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tu...
Yahoo News
over six months ago at news.google.com         
InspireMD vs. TriSalus Life Sciences Head to Head Comparison - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Comparing InspireMD Boston Scientific - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
InspireMD Earns Sell Rating from Analysts at StockNews.com - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
InspireMD Coverage Initiated by Analysts at StockNews.com - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
InspireMD Now Covered by Analysts at StockNews.com - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Financial Contrast InspireMD versus Orthofix Medical - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about InspireMD that are available to investors today. That information is available publicly through InspireMD media outlets and privately through word of mouth or via InspireMD internal channels. However, regardless of the origin, that massive amount of InspireMD data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of InspireMD news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of InspireMD relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to InspireMD's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive InspireMD alpha.

InspireMD Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635
11/08/2024
2
InspireMD GAAP EPS of -0.16, revenue of 1.81M beats by 0.07M
11/12/2024
3
InspireMD, Inc. Q3 2024 Earnings Call Transcript
11/13/2024
4
InspireMD Third Quarter 2024 Earnings US0.16 loss per share
11/14/2024
5
Insider Trading
11/25/2024
6
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization ...
12/09/2024
7
InspireMD, Inc. CFO Craig Shore to Retire, Company Initiates Search for SuccessorDecember 12, 2024-
12/12/2024
8
Acquisition by Roubin Gary S of 30625 shares of InspireMD at 1.3827 subject to Rule 16b-3
12/27/2024

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.